Cargando…

The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review

OBJECTIVE: Based on a thorough analysis of monotherapy (pembrolizumab) and chemoimmunotherapy, the immunomodulatory effects of chemotherapy agents are emphasized. BACKGROUND: The combination of chemotherapy and immune checkpoint inhibitors should and is already being regarded as a new standard strat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Xiangu, Yu, Yang, Shao, Songjun, Deng, Rong, Yu, Jie, Wang, Xuming, She, Xueke, Huang, Depei, Shen, Xudong, Duan, Weiming, Duan, Jin, Zhang, Hushan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667101/ https://www.ncbi.nlm.nih.gov/pubmed/34988212 http://dx.doi.org/10.21037/atm-21-4878

Ejemplares similares

The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
por: Zhao, Xiaolong, et al.
Publicado: (2021)

Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers
por: Lei, Youming, et al.
Publicado: (2022)

Landscape of RB1 alterations in 22,432 Chinese solid tumor patients
por: Xu, Guanghui, et al.
Publicado: (2022)

Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location
por: Shi, Chengmin, et al.
Publicado: (2023)

Immune Microenvironment: New Insight for Familial Adenomatous Polyposis
por: Yang, Jun, et al.
Publicado: (2021)

M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study
por: Wang, Shu, et al.
Publicado: (2023)

Variation of the ileocolic artery and superior mesenteric artery in a patient with right-sided colon cancer with Lynch syndrome: a case report
por: Du, Kunli, et al.
Publicado: (2022)

Case Report: Response to Almonertinib in a Patient With Metastatic NSCLC Resistant to Osimertinib due to Acquired EGFR L718Q Mutation
por: Shen, Gang, et al.
Publicado: (2021)

History of cardiopulmonary resuscitation in ancient China: a narrative review
por: Yu, Yang, et al.
Publicado: (2020)

Conversion therapy with immunotherapy plus chemotherapy achieves a pathological complete response in stage IIIC NSCLC
por: Fu, Yu, et al.
Publicado: (2023)

Neoadjuvant immunotherapy in non-small cell lung cancer: a narrative review on mechanisms, efficacy and safety
por: Shao, Lan, et al.
Publicado: (2022)

Combined Immunotherapy with Chemotherapy versus Bevacizumab with Chemotherapy in First-Line Treatment of Driver-Gene-Negative Non-Squamous Non-Small Cell Lung Cancer: An Updated Systematic Review and Network Meta-Analysis
por: Chai, Yue, et al.
Publicado: (2022)

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
por: Xia, Wu-Yan, et al.
Publicado: (2020)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
por: Dong, Jingsi, et al.
Publicado: (2019)

Functional connectivity of the attention networks is altered and relates to neuropsychological outcomes in children with prenatal alcohol exposure
por: Ware, Ashley L., et al.
Publicado: (2021)

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
por: Zhang, Lei, et al.
Publicado: (2022)

G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer
por: Duan, Lianhui, et al.
Publicado: (2022)

Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
por: Gatteschi, Lavinia, et al.
Publicado: (2021)

Chemotherapy: A partnership with immunotherapy in non‐small cell lung cancer
por: Mendes, Ana Sofia, et al.
Publicado: (2022)

Current applications and future prospects of nanotechnology in cancer immunotherapy
por: Yan, Sen, et al.
Publicado: (2019)

Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy
por: Peng, Jinrong, et al.
Publicado: (2021)

Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain
por: Duan, Zongsheng, et al.
Publicado: (2018)

Anesthetic effect of propofol combined with remifentanil or sevoflurane anesthesia on patients undergoing radical gastrectomy
por: Feng, Yazhen, et al.
Publicado: (2019)

Hyperprogression under immunotherapy: a new form of immunotherapy response?—a narrative literature review
por: Lin, Miaozhen, et al.
Publicado: (2021)

Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy
por: Guo, Tiantian, et al.
Publicado: (2020)

Narrative review of immunotherapy in thymic malignancies
por: Benitez, Jose Carlos, et al.
Publicado: (2021)

Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An updated systematic review and meta‐analysis
por: Chai, Yue, et al.
Publicado: (2022)

Indirect comparison between immunotherapy alone and immunotherapy plus chemotherapy as first-line treatment for advanced non-small cell lung cancer: a systematic review
por: Li, Lingling, et al.
Publicado: (2020)

Immunotherapy in small cell lung cancer: one step at a time: a narrative review
por: Dumoulin, Daphne W., et al.
Publicado: (2021)

A narrative review of current and potential prognostic biomarkers for immunotherapy in small-cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review
por: Montrone, Michele, et al.
Publicado: (2023)

Cytotoxic effect of CLL-1 CAR-T cell immunotherapy with PD-1 silencing on relapsed/refractory acute myeloid leukemia
por: Lin, Guoqiang, et al.
Publicado: (2021)

Mechanism of gastrodin in cell apoptosis in rat hippocampus tissue induced by desflurane
por: Wang, Luping, et al.
Publicado: (2018)

Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation
por: Duan, Zongsheng, et al.
Publicado: (2020)

A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy
por: Li, Shuyan, et al.
Publicado: (2020)

Antifungal chemotherapies and immunotherapies for the future
por: Armstrong‐James, Darius
Publicado: (2022)

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
por: Cai, Liangliang, et al.
Publicado: (2023)

Primary small cell esophageal carcinoma, chemotherapy sequential immunotherapy: A case report
por: Wu, Yong-Hui, et al.
Publicado: (2021)

Checkpoint blockade‐based immunotherapy in the context of tumor microenvironment: Opportunities and challenges
por: Duan, Jingjing, et al.
Publicado: (2018)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v0i8ulp9fivu56vbvifu83l0hh